Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Unicorn Biotechnologies

Unicorn Biotechnologies is a developer of bio-reactors designed for cell-based manufacturing.
2020
Nov-50
11-50
Sheffield, Sheffield, United Kingdom

Innovation

Industry Problem

Manual cell-culture workflows are labour-intensive, variable and difficult to transfer reliably from research to manufacturing scale.

R&D Focus

Automated cell culture, robotics and scalable regenerative-medicine bioprocessing.

Innovative Solution

Develops general-purpose cell-culture robots that automate expansion and differentiation workflows and support transfer to scalable manufacturing systems.

Solution Effectiveness

An official application note reports more than 96% cardiomyocyte purity from automated hiPSC differentiation; other website testimonials are not independently verifiable.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

3.2M

Last Funding Amount

3.2M

Last Funding Date

21-04-2022

Startup Stage

Seed

Lead Investors

Alumni Ventures, SOSV, Acequia Capital (AceCap), Cult Food Science, Unruly Capital

Revenue

$1M to $10M

People

Founders

About

Unicorn Biotechnologies is developing a next-generation biomanufacturing platform to power the cell-based manufacturing revolution, starting with cultivated meat. By providing a clear path to affordably and rapidly scale cultivated meat, we will improve human and planetary health and drive the transition to animal-free agriculture.

Products

Product

Emmet automated cell-culture system and related machines and services.

Star Product

Emmet – the company’s automated bench-top cell-culture platform.

Demo Product or Complete Product?

Commercial or evaluation-stage cell-culture automation systems and services.

Something missing or incorrect on this page? Help us enrich this information